PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
-2.4%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$5.32B
AUM Growth
+$5.32B
(-3.7%)
Cap. Flow
+$25.9M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
23.94%
Holding
303
New
29
Increased
89
Reduced
98
Closed
32
Top Buys
| 1 |
Union Pacific
UNP
|
$48M |
| 2 |
Gilead Sciences
GILD
|
$37.7M |
| 3 |
BCR
CR Bard Inc.
BCR
|
$33.4M |
| 4 |
CVS Health
CVS
|
$29.7M |
| 5 |
Danaher
DHR
|
$28.5M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$36.9M |
| 2 |
PNC Financial Services
PNC
|
$34M |
| 3 |
CELG
Celgene Corp
CELG
|
$31.5M |
| 4 |
Accenture
ACN
|
$29.9M |
| 5 |
Waste Connections
WCN
|
$29M |
Sector Composition
| 1 | Technology | 24.14% |
| 2 | Healthcare | 23.21% |
| 3 | Financials | 21.91% |
| 4 | Communication Services | 10% |
| 5 | Industrials | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$3.45T
| $200M | 3.76% | 1,833,489 +92,659 | +5% | +$10.1M |
|
2
Alphabet (Google) Class C
GOOG
$2.58T
| $186M | 3.49% | 249,279 -23,511 | -9% | -$17.5M |
|
3
Johnson & Johnson
JNJ
$427B
| $182M | 3.42% | 1,681,519 -17,523 | -1% | -$1.9M |
|
4
Chubb
CB
$110B
| $135M | 2.55% | 1,136,029 +64,340 | +6% | +$7.67M |
|
5
Microsoft
MSFT
$3.77T
| $108M | 2.04% | 1,961,866 -128,329 | -6% | -$7.09M |
|
6
Meta Platforms (Facebook)
META
$1.86T
| $108M | 2.04% | 948,656 +13,266 | +1% | +$1.51M |
|
|
7
Alphabet (Google) Class A
GOOGL
$2.57T
| $95.6M | 1.8% | 125,401 -1,670 | -1% | -$1.27M |
|
8
Berkshire Hathaway Class B
BRK.B
$1.09T
| $90.5M | 1.7% | 637,889 +197,109 | +45% | +$28M |
|
9
Pfizer
PFE
$141B
| $83.9M | 1.58% | 2,831,036 +97,792 | +4% | +$2.9M |
|
10
Arch Capital
ACGL
$34.2B
| $83.4M | 1.57% | 1,173,456 -5,114 | -0.4% | -$364K |
|
11
Markel Group
MKL
$24.8B
| $82.6M | 1.55% | 92,696 -3,530 | -4% | -$3.15M |
|
12
Visa
V
$683B
| $79.7M | 1.5% | 1,041,866 -32,549 | -3% | -$2.49M |
|
13
Intel
INTC
$107B
| $73.1M | 1.37% | 2,258,741 -250,609 | -10% | -$8.11M |
|
14
JPMorgan Chase
JPM
$829B
| $70.3M | 1.32% | 1,187,022 +168,463 | +17% | +$9.98M |
|
15
Citigroup
C
$178B
| $68.8M | 1.29% | 1,648,288 +289,502 | +21% | +$12.1M |
|
|
VR
16
DELISTED
Validus Hold Ltd
VR
| $68.6M | 1.29% | 1,453,363 +55,810 | +4% | +$2.63M |
|
|
BCR
17
DELISTED
CR Bard Inc.
BCR
| $68.5M | 1.29% | 337,992 +164,596 | +95% | +$33.4M |
|
18
Amdocs
DOX
$9.41B
| $64.9M | 1.22% | 1,073,479 +177,023 | +20% | +$10.7M |
|
19
Elevance Health
ELV
$71.8B
| $63.8M | 1.2% | 459,317 -1,995 | -0.4% | -$277K |
|
20
Fidelity National Information Services
FIS
$36.5B
| $62.4M | 1.17% | 985,131 -3,088 | -0.3% | -$196K |
|
21
Medtronic
MDT
$119B
| $60.3M | 1.13% | 803,357 -341,719 | -30% | -$25.6M |
|
22
PepsiCo
PEP
$204B
| $57.9M | 1.09% | 564,540 -645 | -0.1% | -$66.1K |
|
|
QVCGA
23
QVC Group, Inc. Series A Common Stock
QVCGA
$69.2M
| $57.2M | 1.08% | 2,264,059 -3,055 | -0.1% | -$77.1K |
|
24
Eli Lilly
LLY
$657B
| $57.2M | 1.08% | 793,778 -41,222 | -5% | -$2.97M |
|
|
25
Accenture
ACN
$162B
| $57.1M | 1.08% | 495,189 -259,089 | -34% | -$29.9M |
|